Oruka Therapeutics, Inc. ORKA Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s cash cash equivalents restricted cash and restricted cash equivalents period increase decrease excluding exchange rate effect.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s cash cash equivalents restricted cash and restricted cash equivalents period increase decrease excluding exchange rate effect?
- Oruka Therapeutics, Inc. (ORKA) reported cash cash equivalents restricted cash and restricted cash equivalents period increase decrease excluding exchange rate effect of $2.59M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s cash cash equivalents restricted cash and restricted cash equivalents period increase decrease excluding exchange rate effect changed year-over-year?
- Oruka Therapeutics, Inc.'s cash cash equivalents restricted cash and restricted cash equivalents period increase decrease excluding exchange rate effect decreased by 88.2% year-over-year, from $22M to $2.59M.
- What does cash cash equivalents restricted cash and restricted cash equivalents period increase decrease excluding exchange rate effect mean?
- Measures the net change in the total cash position, including restricted cash, over a specific reporting period. It provides a comprehensive view of the company's net cash burn or accumulation after accounting for operating, investing, and financing activities.